TEVA PHARMACEUTICALS
Supplier Forensic Analysis · Scanned: 2026/07/30
Open this supplier in the workbench →These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.
CIPC screening
ClearCompliance
N/A/100
Awards
3
Total Value
R 189M
Recent Awards
3 awards · Total: R 189 025 505,35
Erratum Notice 1 : Addition of 18 to the Item list for HP02-2025AI/01: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the Period ending 30 September 2028
Health and Welfare Sector Education and Training Authority
Ref: HP02-2025AI/01R 23 619 321,00
18 Jun 2026
HP04-2026ONC: SUPPLY AND DELIVERY OF ONCOLOGY AND IMMUNOLOGICAL AGENTS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 JULY 2026 TO 30 JUNE 2028
Health and Welfare Sector Education and Training Authority
Ref: HP04-2026ONCR 69 372 763,44
12 Jun 2026
HP09-2026SD: SUPPLY AND DELIVERY OF SOLID DOSAGE FORMS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 MAY 2026 TO 30 APRIL 2029
Health and Welfare Sector Education and Training Authority
Ref: HP09-2026SDR 96 033 420,91
02 Apr 2026
AI Analysis
Powered by GeminiAI Forensic Analysis
Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo
or upgrade to Pro Subscription
Procurement context
Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.
Unlock forensic context →CIPC screening signalsClear
No contributing warning signals in the current evidence.
Unlock Full Analysis
Get access to all forensic flags, evidence details, and AI-generated audit narratives.
View Full Intelligence Report
Get complete award history, director network, and compliance analysis.
View Report →